| 摘要 |
The present invention provides heterocyclylamine derivatives of Formula I: wherein the variables are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases. |
| 申请人 |
Incyte Holdings Corporation |
发明人 |
LI, Yun-Long;YAO, Wenqing;COMBS, Andrew, P.;YUE, Eddy, W.;MEI, Song;ZHU, Wenyu;GLENN, Joseph;MADUSKUIE, Thomas, P., Jr.;SPARKS, Richard, B.;DOUTY, Brent;HE, Chunhong |
